Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis.
Saved in:
| Title: | Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis. |
|---|---|
| Authors: | Tarkiainen, Maarit1,2,3 (AUTHOR) maarit.tarkiainen@helsinki.fi, Tynjälä, Pirjo2,3 (AUTHOR), Vähäsalo, Paula4,5 (AUTHOR), Aalto, Kristiina1,2,3 (AUTHOR), Kröger, Liisa6 (AUTHOR), Rebane, Katariina1,2,3 (AUTHOR), Lahdenne, Pekka1,2,3 (AUTHOR), Martikainen, Janne7 (AUTHOR) |
| Source: | Pediatric Rheumatology. 11/16/2022, Vol. 20 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 160458152 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Tarkiainen%2C+Maarit%22">Tarkiainen, Maarit</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> maarit.tarkiainen@helsinki.fi</i><br /><searchLink fieldCode="AR" term="%22Tynjälä%2C+Pirjo%22">Tynjälä, Pirjo</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vähäsalo%2C+Paula%22">Vähäsalo, Paula</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aalto%2C+Kristiina%22">Aalto, Kristiina</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kröger%2C+Liisa%22">Kröger, Liisa</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rebane%2C+Katariina%22">Rebane, Katariina</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lahdenne%2C+Pekka%22">Lahdenne, Pekka</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martikainen%2C+Janne%22">Martikainen, Janne</searchLink><relatesTo>7</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Pediatric+Rheumatology%22">Pediatric Rheumatology</searchLink>. 11/16/2022, Vol. 20 Issue 1, p1-8. 8p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=160458152 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12969-022-00748-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 1 Titles: – TitleFull: Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tarkiainen, Maarit – PersonEntity: Name: NameFull: Tynjälä, Pirjo – PersonEntity: Name: NameFull: Vähäsalo, Paula – PersonEntity: Name: NameFull: Aalto, Kristiina – PersonEntity: Name: NameFull: Kröger, Liisa – PersonEntity: Name: NameFull: Rebane, Katariina – PersonEntity: Name: NameFull: Lahdenne, Pekka – PersonEntity: Name: NameFull: Martikainen, Janne IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 11 Text: 11/16/2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 15460096 Numbering: – Type: volume Value: 20 – Type: issue Value: 1 Titles: – TitleFull: Pediatric Rheumatology Type: main |
| ResultId | 1 |